This is a StreetInsider.com Premium Only Page

(XERS) –

Apr 11, 2024 04:06 PM Form 4 Xeris Biopharma Holdings For: Mar 15 Filed by: SHERMAN JEFFREY W

Apr 3, 2024 04:05 PM Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Apr 2, 2024 07:00 AM Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Apr 1, 2024 05:45 PM Form 4 Xeris Biopharma Holdings For: Mar 15 Filed by: Kong Garheng

Apr 1, 2024 05:43 PM Form 4 Xeris Biopharma Holdings For: Mar 15 Filed by: JOHNSON JOHN

Mar 27, 2024 04:04 PM Oppenheimer Starts Xeris Pharmaceuticals (XERS) at Outperform, 'successful commercial execution will continue to drive top-line growth'

Mar 18, 2024 05:32 PM Form 4 Xeris Biopharma Holdings For: Mar 18 Filed by: JOHNSON JOHN

Mar 14, 2024 09:04 PM Form 4 Xeris Biopharma Holdings For: Mar 14 Filed by: Schmid John P.

Mar 7, 2024 06:39 AM Xeris Pharmaceuticals (XERS) PT Raised to $6 at H.C. Wainwright

Mar 6, 2024 04:11 PM Form 10-K Xeris Biopharma Holdings For: Dec 31

Mar 6, 2024 07:27 AM Form 8-K Xeris Biopharma Holdings For: Mar 05

Mar 6, 2024 07:04 AM Xeris Pharmaceuticals Inc. (XERS) Misses Q4 EPS by 1c, provides guidance

Mar 6, 2024 07:02 AM Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events

Mar 6, 2024 07:00 AM Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital

Feb 28, 2024 07:00 AM Xeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024

Feb 13, 2024 06:27 PM Form SC 13G Xeris Biopharma Holdings Filed by: VANGUARD GROUP INC

Feb 13, 2024 04:35 PM Form SC 13G/A Xeris Biopharma Holdings Filed by: Stonepine Capital Management, LLC

Feb 5, 2024 07:00 AM Xeris to Present at the Oppenheimer 34th Annual Healthcare Life Science Conference

Jan 31, 2024 05:05 PM Form 4 Xeris Biopharma Holdings For: Jan 31 Filed by: Pieper Steven

Jan 31, 2024 05:05 PM Form 4 Xeris Biopharma Holdings For: Jan 31 Filed by: JOHNSON KENNETH ERLAND

Jan 31, 2024 05:05 PM Form 4 Xeris Biopharma Holdings For: Jan 31 Filed by: Hecht Beth

Jan 31, 2024 05:05 PM Form 4 Xeris Biopharma Holdings For: Jan 31 Filed by: Shannon John Patrick Jr

Jan 31, 2024 05:05 PM Form 4 Xeris Biopharma Holdings For: Jan 31 Filed by: Edick Paul R

Jan 26, 2024 04:25 PM Form SC 13G Xeris Biopharma Holdings Filed by: BlackRock Inc.

Jan 10, 2024 09:02 AM Xeris Pharmaceuticals Inc. (XERS) Enters Into an Exclusive Worldwide License Agreement for Xeriject Formulation of Teprotumumab

Jan 10, 2024 08:00 AM Xeris Biopharma Enters Into an Exclusive Worldwide License Agreement for Xeriject® Formulation of Teprotumumab

Jan 5, 2024 04:05 PM Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Jan 4, 2024 07:09 AM Form 8-K Xeris Biopharma Holdings For: Jan 04

Jan 4, 2024 07:04 AM Xeris Pharmaceuticals (XERS) Updates 2023 Outlook

Jan 4, 2024 07:00 AM Xeris Biopharma Updates Its Outlook for 2023

Dec 27, 2023 07:00 AM Xeris Biopharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Nov 29, 2023 04:09 PM Form 4 Xeris Biopharma Holdings For: Nov 27 Filed by: SHERMAN JEFFREY W

Nov 21, 2023 04:27 PM Form 4 Xeris Biopharma Holdings For: Nov 20 Filed by: HALKUFF DAWN

Nov 21, 2023 04:23 PM Form 4 Xeris Biopharma Holdings For: Nov 20 Filed by: Pieper Steven

Nov 17, 2023 06:36 PM Form 4 Xeris Biopharma Holdings For: Nov 16 Filed by: Schmid John P.

Nov 17, 2023 05:59 PM Form 4 Xeris Biopharma Holdings For: Nov 17 Filed by: Shannon John Patrick Jr

Nov 15, 2023 04:13 PM Form 4 Xeris Biopharma Holdings For: Nov 14 Filed by: PERSKY MARLA

Nov 13, 2023 06:41 AM Xeris Pharmaceuticals (XERS) PT Lowered to $5.50 at H.C. Wainwright

Nov 10, 2023 07:36 AM Xeris Pharmaceuticals (XERS) PT Lowered to $4 at Piper Sandler

Nov 9, 2023 04:12 PM Form 10-Q Xeris Biopharma Holdings For: Sep 30

Nov 9, 2023 07:20 AM Form 8-K Xeris Biopharma Holdings For: Nov 09

Nov 9, 2023 07:05 AM Xeris Pharmaceuticals Inc. (XERS) Tops Q3 EPS by 1c

Nov 9, 2023 07:00 AM Xeris Biopharma Reports Third Quarter 2023 Financial Results

Oct 16, 2023 07:12 AM Form 8-K Xeris Biopharma Holdings For: Oct 16

Oct 16, 2023 07:01 AM Xeris Pharmaceuticals Inc. (XERS) Raises Full-Year Financial Guidance and Reaffirms Cash Flow Breakeven in Q4

Oct 16, 2023 07:00 AM Xeris Biopharma Raises Full-Year Financial Guidance and Reaffirms Cash Flow Breakeven in Q4 2023

Sep 29, 2023 05:02 PM Form 8-K Xeris Biopharma Holdings For: Sep 29

Sep 27, 2023 08:12 AM Form 8-K Xeris Biopharma Holdings For: Sep 26

Sep 27, 2023 08:07 AM Xeris Pharmaceuticals Inc. (XERS) Announces Private Convertible Note Exchange Transactions

Sep 27, 2023 08:00 AM Xeris Biopharma Announces Private Convertible Note Exchange Transactions